About the Cancer Vaccine Development Session
In the dynamic realm of cancer research, the quest for a viable cancer vaccine stands as a beacon of hope. Unlike conventional vaccines that combat infectious diseases, cancer vaccines leverage the body's immune system to target and eradicate cancerous cells. Various innovative approaches, including peptide vaccines and dendritic cell vaccines, are being vigorously explored. These vaccines hold immense potential not only in preventing cancer recurrence but also in treating existing tumors with diminished side effects compared to conventional therapies like chemotherapy. Despite hurdles like antigen identification and tumor immunosuppression, ongoing research persists, promising increasingly effective and personalized cancer treatment avenues on the horizon.
Topics Covered in Cancer Vaccine Development
Peptide Vaccines
Dendritic Cell Vaccines
Nucleic Acid Platforms
Immune Adjuvants
Neoantigen Selection
Immune Response Monitoring
Related Scientific Sessions at CIOC 2027
Why Attend the Cancer Vaccine Development Conference 2027
Earn CPD Credit
Sessions are CPD-accredited; certificates issued to every registered delegate within two weeks of the conference.
Present Your Research
Oral and poster slots for original Cancer Vaccine Development work, reviewed by the scientific committee.
Network Globally
Meet oncologists, cancer researchers, and clinical specialists from around the world across three days.
Publish & Get Indexed
Accepted abstracts appear in the indexed conference proceedings with a citable DOI.
Learn from Keynotes
Plenary lectures from leading voices shaping Cancer Vaccine Development research and practice.
Hybrid Flexibility
Attend in person in Singapore or join virtually — same programme, same certificate.
Join CIOC 2027 for the Cancer Vaccine Development track
Oral and poster slots for your work — in person in Singapore or online. Not presenting? Attend as a delegate to learn from the field.
Cancer Vaccine Development Conference 2027 — FAQs
What is the Cancer Vaccine Development track at CIOC 2027?
The Cancer Vaccine Development track is a dedicated stream within CIOC 2027 covering the latest research, clinical innovation, and best practice in Cancer Vaccine Development. It brings together researchers, educators, and practitioners for oral presentations, posters, and discussion.
Who should attend the Cancer Vaccine Development sessions?
Cancer researchers and clinicians, educators and students with an interest in Cancer Vaccine Development are all welcome — whether presenting or attending.
Can I present my research in the Cancer Vaccine Development track?
Yes. Submit an abstract for oral or poster presentation. All submissions are peer-reviewed by the scientific committee; accepted abstracts appear in the indexed proceedings.
Is virtual attendance available for Cancer Vaccine Development sessions?
Yes. CIOC 2027 is a hybrid conference — attend the Cancer Vaccine Development track in person in Singapore or join live online, with on-demand access afterward.
Join the CIOC 2027 delegation
Singapore · March 15–17, 2027· Hybrid · in-person & virtual
Attend without presenting.